Eufy Security Wall Light Cam S4 Deal: Save $80 on This Versatile Gadget
This feature-packed security camera is the perfect way to keep an eye on your home and fam from afar.
Original NEXXIS analysis and curated technology and business headlines from trusted publishers.
Headlines and short excerpts are provided by each publisher’s RSS feed. Every story links to the original article on the publisher’s site.
This feature-packed security camera is the perfect way to keep an eye on your home and fam from afar.
Trump’s EPA can't unilaterally dismiss SpaceXAI pollution lawsuit, court rules.
Source: Ars Technica · Ashley Belanger
It's one of the biggest overhauls ever to the 30-year-old connected car product.
This is the kind of security issue that was found and prevented by AI, but is also a high risk because of AI.
Source: TechCrunch · Julie Bort
Blacksmith, a platform that lets companies build and test AI code more effectively, just announced a $66 million Series C round led by Sequoia that values the company at $1 billion.
Source: TechCrunch · Dominic-Madori Davis
Recursive makes the case that the benefits of using AI to build AI outweigh the risks.
OpenEvidence is booming despite questions about accuracy and ads.
Source: Ars Technica · Rafe Rosner-Uddin, Financial Times
At Nvidia’s GTC in Berlin, Huang unveiled the company’s new plug-in data center—the DSX Pod—as the key to unlocking Europe’s AI infrastructure lag. Oh, and autonomous humanoid robotics.
The PHP Foundation has revealed two serious vulnerabilities that could impact millions of websites. Security experts warn that failure to quickly patch the flaws could have dire consequences.
Source: WIRED · Matt Burgess, Lily Hay Newman
More than 50% of managers say they're finding it harder to evaluate employees' work after adopting AI, according to a new survey.
Hackers around the world are all-in on using agentic AI to wage attacks—and manipulating tools like Anthropic’s Claude to help them carry out their crimes.
Source: WIRED · Lily Hay Newman
The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.